Genetic Counselling in the Prevention of Mental Health Consequences of Cannabis Use

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

November 1, 2019

Primary Completion Date

September 1, 2026

Study Completion Date

September 1, 2027

Conditions
Mental IllnessSchizophreniaBipolar DisorderMajor Depressive DisorderCannabis UsePsychosis
Interventions
BEHAVIORAL

Genetic counselling

Participants will receive information on risk/protective factors and causes of mental illness. Participants are not required to receive numeric/genetic risk information. Participants who choose to receive genetic and/or numeric risk information will be counselled on their risk of NOT developing and of developing SMI based on their genetic test results and/or family history information they provide. Risk estimates will be derived by genetic counsellors, according to standard practice guidelines. Participants who receive genetic information will be counselled on the possible influence of cannabis use on risk of mental illness based on their genotype. Participants who choose to not receive genetic information will be counselled on the influence of cannabis on mental health.

Trial Locations (1)

B3H 2E2

RECRUITING

Nova Scotia Health Authority, Halifax

All Listed Sponsors
lead

Nova Scotia Health Authority

OTHER